RTI Questions

1. Please provide copies of safety, efficacy,and all other relevant data submitted by the serum institute of India (sii) for its Mr vaccine ‘Tresivac’ to the drugs controller general (India) for emergency use approvel.
2. Have you conducted safety studies on 6 month old children for administering MR vaccines ?
3. Some mainstream news reports show that government has increased the doses of the MR vaccine for children to show that it provides additional benefit to children. Please provide copies of studies conducted of safety and clinical trial data that you have conducted which proves that increasing dose of MR vaccine for children provides some additional benefit
4. Please provide a copy of the final report submitted by the subject experts committee (tasked to assess the MR vaccine approved application of TRESIVAC amonst others) to the drug controller of india.

Download here